On July 20, the Ministry of Industry and Information Technology of the People's Republic of China released national "List of the Third Batch of Specialized, Fined, Peculiar and Innovative "Small Giant" Enterprises", and Biosis Healing was included in the public list. In the "Beijing 2021 Third Batch of SMEs to recognized as "Specialized, Fined, Peculiar and Innovative" List", which has recently been publicized, Biosis Healing passed the publicity and was formally approved as a "Beijing Specialized, Fined, Peculiar and Innovative Small Giant Enterprise".
Biosis Healing listed in national "Publicity List of the Third Batch of Specialized, Fined, Peculiar and Innovative "Small Giant" Enterprises"
National policy support to enhance the potential and competitiveness of small giant enterprises
Specialized, Fined, Peculiar and Innovative small giant enterprises are outstanding enterprises among Specialized, Fined, Peculiar and Innovative enterprises, which are pioneer enterprises focusing on market subdivision, strong innovation ability, high market share, mastering key core technologies, and excellent quality and efficiency.
According to the previously released "Supporting the High-Quality Development of "Specialized, Fined, Peculiar and Innovative "SMEs" (Caijian  No.2), the "Notice" clearly stated that key small giant enterprises will be supported to increase their investment in innovation and promote the industrialized application of technological achievements, promote the "four bases" fields of the industry or the ten key industries with a clear strategy for a strong manufacturing country to "make up for shortcomings" and "forge advantages", speed up the listing, strengthen international cooperation, etc., to further enhance the development potential and international competitiveness of small giant enterprises.
Biosis Healing officially recognized as "Beijing Specialized, Fined, Peculiar and Innovative Small Giant" Enterprise"
SIS biomaterials break the domestic gap
"Key basic materials" is an important part of the industrial "four bases" field. Prior to the establishment of Biosis Healing, the production and preparation technology of SIS biomaterials were monopolized by the United States. For a long time, domestic patients could only use SIS biological graft produced in the United States. In order to solve the problem to break the domestic gap and the US technology monopoly, Biosis Healing has been committed to the research and development and industrialization of SIS biomaterials since its establishment in 2012.
In the past 9 years, Biosis Healing has completed the construction and industrialization of the SIS material preparation technology platform with independent intellectual property rights. From the domestic blank of SIS biomaterials, to break the bottleneck and find a way to independent research and development, nowadays, Biosis Healing has become a leader in the field of domestic SIS biomaterials, and has a strength compete with international brands.
It not only solved the problem to break the domestic gap of domestic key basic materials and opened the door to the international market to compete with the American brand on the world stage.
Make up for shortcomings, degradable and absorbent tissue glue products solve clinical pain points
The absorbable medical tissue glue product being researched by Biosis Healing is also the key product recognized by the "Beijing Specialized, Fined, Peculiar and Innovative Small Giant Enterprise"
It solves the demands pain points and technical shortcomings of rapid hemostasis, tissue adhesion and wound closure clinically. In addition, the tissue glue is safe, non-toxic, biodegradable, short gel time, mechanical properties matching the tissue, and strong adhesion can be maintained in a humid environment. Once on sale, it will solve key clinical problems, bring better operating experience to doctors, and better postoperative recovery effects for patients.
At present, the domestic and international environment is complex and severe. the needs to build China into a world leader in science and technology, achieve high-level technological self-reliance are more urgent than ever. Looking at the world, a new round of scientific and technological revolution and industrial transformation are reconstructing the global innovation landscape, and seizing the opportunity to win the future. Looking back at the domestic, whether it is to promote high-quality development, build a new development pattern, improve people's quality of life, and ensure national security, strong scientific and technological support is needed. New industry giants represented by technological innovation are constantly emerging. Under the support of national policies, the small giant will also develop rapidly and shine in the context of international and domestic technological revolutions and industrial changes.